Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
Neuro-Oncology|June 26, 2020
Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphomaYoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, et al.
Molecular and Cellular Biology|January 24, 2019
Generation and Molecular Characterization of Human Ring Sideroblasts: a Key Role of Ferrous Iron in Terminal Erythroid Differentiation and Ring Sideroblast FormationKei Saito, Tohru Fujiwara, Shunsuke Hatta, et al.
The American Journal of Surgical Pathology|April 7, 2025
High FCGR2B Expression Can Identify Low-tumor-burden Follicular Lymphoma Patients Who Do Not Require Any Antilymphoma Therapy for a Long TermShotaro Watanabe, Hiroki Kato, Tohru Fujiwara, et al.
Biochemical and Biophysical Research Communications|December 3, 2014
Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemiaTohru Fujiwara, Koji Okamoto, Ryoyu Niikuni, et al.
Cancer Science|March 1, 2019
Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in JapanWataru Munakata, Kiyoshi Ando, Kiyohiko Hatake, et al.
International Journal of Hematology|November 20, 2022
Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trialNoriko Fukuhara, Koji Kato, Hideki Goto, et al.
International Journal of Clinical Oncology|September 2, 2025
Long-term outcomes of venetoclax and ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphomaHideki Goto, Satoshi Ito, Masahiro Kizaki, et al.
Experimental Hematology & Oncology|August 7, 2013
Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxisSatoshi Ichikawa, Noriko Fukuhara, Ai Inoue, et al.
Cancer Science|March 8, 2017
Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphomaDai Maruyama, Kiyohiko Hatake, Tomohiro Kinoshita, et al.
Scientific Reports|August 26, 2022
Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndromeTetsuro Ochi, Tohru Fujiwara, Koya Ono, et al.
Pageof 17